Delivery Order SPE2DR25D6028-SPE2DR26FASBF
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025, for the supply of Sodium Chloride 3% in a 24-unit configuration. This firm fixed-price delivery order, valued at $11,501.60, is scheduled for completion by September 24, 2025, and represents a non-set-aside, competitively awarded contract. The work will be performed at the contractor's Corporate Office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 2, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Sodium Chloride 0.9% in 50ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,707.50 and an ultimate completion date of May 5, 2025. This award was competitively awarded with no set-aside designation and represents a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $15,188.88 on October 7, 2025, for the supply of Sodium Chloride 0.9% solution in 100mL quantities (96 units) to support military and federal healthcare needs. This delivery order is classified as firm fixed price with an ultimate completion date of November 4, 2025, and was issued under the Defense Logistics Agency Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on September 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Sodium Chloride 0.9% Solution in 250ml units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,042.60 and is scheduled for ultimate completion by September 5, 2025. The delivery order falls under a firm fixed-price arrangement, with...
- The Defense Logistics Agency Medical Supply Chain awarded a $34.2K delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Sodium Chloride 3% in 24-count packaging. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The delivery order has an...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $19,119.76 to AmerisourceBergen Drug Corp for the supply of Sodium Chloride 3% (24-pack) on August 22, 2025, with completion expected by September 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,373.81 by the Defense Logistics Agency's Medical Supply Chain for sodium chloride irrigation solution on November 18, 2024, with completion scheduled for November 19, 2024. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $6,406.39 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Sodium Chloride 0.9% Solution in 500 mL units, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sodium Chloride 3% 24S with a ceiling value of $1,554.60 under a firm fixed price contract. The award was made on June 3, 2025, with an ultimate completion date of the same day. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,244.58 for sodium chloride 0.9% solution in 100mL quantities, with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under a larger indefinite delivery contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASBFDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Sodium Chloride 3% (24-pack) by the Defense Logistics Agency on November 25, 2025, with a ceiling value of $19,399.68 and an ultimate completion date of December 23, 2025. This is a firm fixed-price, non-set-aside contract that leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where the vendor's corporate office is situated. This delivery order represents a routine procurement of an essential saline solution product for federal medical supply needs, likely supporting military and veteran healthcare systems across the Department of Defense. As a child contract under the larger SPE2DX indefinite delivery vehicle, this award demonstrates AmerisourceBergen's ongoing role as a critical vendor for the DLA Medical Supply Chain. The contract's firm fixed pricing and non-competitive set-aside status reflect the competitive nature of AmerisourceBergen's federal pharmaceutical procurement portfolio, which encompasses a wide range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 11/24/25 |